---
schema_version: "secwatch.filing_event.v1"
accession: "0000927653-25-000125"
form_type: "8-K"
ticker: "MCK"
cik: "0000927653"
company_name: "MCKESSON CORP"
filed_at: "2025-09-23T23:59:59+00:00"
generated_at: "2026-05-17T05:56:08.567423+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# McKesson raises FY2026 adj. EPS guidance to $38.05-$38.55; long-term growth target increased to 13%-16%

## Summary
- Fiscal 2026 Adjusted EPS guidance raised and narrowed to $38.05-$38.55 from $37.10-$37.90.
- Long-term Adjusted EPS growth target increased to 13%-16% from prior 12%-14%.
- New segment long-term growth targets: North American Pharmaceutical 5%-8%, Oncology & Multispecialty 13%-16%, Prescription Technology Solutions 10%-13%.
- Medical-Surgical separation and new organizational structure announced on Sept 18, 2025, reaffirmed at Investor Day.
- Investor Day webcast on Sept 23, 2025; Q2 FY2026 earnings scheduled for Nov 5, 2025.

## SEC filing metadata
- accession: 0000927653-25-000125
- form_type: 8-K
- ticker: MCK
- cik: 0000927653
- company_name: MCKESSON CORP
- filed_at: 2025-09-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927653/000092765325000125/0000927653-25-000125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927653/000092765325000125/mck-20250923.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927653-25-000125
- JSON: https://secwatch.observer/filing/0000927653-25-000125.json
- Plain text: https://secwatch.observer/filing/0000927653-25-000125.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.